Loading organizations...
§ Private Profile · Newton, MA, USA
Public benefit corporation providing affordable psychedelic-assisted therapy for workplace mental health benefits.
Enthea is a third-party administrator of employer benefits programs based in an undisclosed location that provides psychedelic-assisted therapy as a workplace mental health benefit. Operating as a public benefit corporation, the company facilitates employee access to treatments such as ketamine-assisted therapy through licensed health plans. The organization closed an initial $2 million tranche of seed funding in late 2022 and projected reaching 100 corporate customers and $250,000 in revenue by the end of 2023, with aims for $4 million in revenue by 2024. Enthea's financial backers include lead investor Tabula Rasa Ventures and Mystic Ventures, while its corporate client roster features Dr. Bronner's, Daybreaker, and Tushy. Originally started as a nonprofit organization in 2020 before restructuring as a public benefit corporation in 2022, the enterprise was formally established and co-founded by Sherry Rais.
Enthea has raised $2.0M across 1 funding round.
Enthea has raised $2.0M in total across 1 funding round.
Enthea has raised $2.0M across 1 funding round. Most recently, it raised $2.0M Seed in December 2022.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Dec 12, 2022 | $2M Seed | Tabula Rasa Ventures | — | Announced |
Enthea has raised $2.0M in total across 1 funding round.
Enthea's investors include Tabula Rasa Ventures.